Evidence map›Paper›PMID 36942097›Full record

ArticleJournal of translational autoimmunity2023

Serum autoantibodies and exploratory molecular pathways in rural miners: A pilot study.

Esther Erdei, Xixi Zhou, Chris Shuey, Nour Ass'ad, Kimberly Page, Bobbi Gore, Chengsong Zhu, Deborah Kanda, Li Luo, Akshay Sood and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational autoimmunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Esther ErdeiCollege of Pharmacy, University of New Mexico- Health Sciences Center, 905 Vassar Drive NE, Albuquerque, NM, 87106, USA.
Xixi ZhouCollege of Pharmacy, University of New Mexico- Health Sciences Center, 905 Vassar Drive NE, Albuquerque, NM, 87106, USA.
Chris ShueySouthwest Research and Information Center, 105 Stanford Drive SE, Albuquerque, NM, 87106, USA.
Nour Ass'adDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA.
Kimberly PageDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA.
Bobbi GoreMiners' Colfax Medical Center, 203 Hospital Drive, Raton, NM, 87740, USA.
Chengsong ZhuDepartment of Immunology and Microarray Core, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Deborah KandaComprehensive Cancer Center, University of New Mexico, Albuquerque, NM, 87106, USA.
Li LuoComprehensive Cancer Center, University of New Mexico, Albuquerque, NM, 87106, USA.
Akshay SoodDepartment of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA.
Katherine E ZychowskiCollege of Nursing, University of New Mexico- Health Sciences Center, 2502 Marble Ave NE, Albuquerque, NM, 87131, USA.
University of New Mexico · USThe University of Texas Southwestern Medical Center · US

Funding

UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI VOJO P DERETIC · 2017 to 2026
$24.9M
UNM Metals Exposure and Toxicity Assessment on tribal Lands in the Southwest (METALS) Superfund Research ProgramP42ES025589 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HUDSON, LAURIE G · 2017 to 2025
$16.4M
Pilot Project CoreP30ES032755 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI FENG, CHANGJIAN (JIM) · 2022 to 2025
$5.2M
Systemic Implications and Novel Mechanisms of Circulating Extracellular Vesicles Following Inhaled ExposuresR01ES033981 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Katherine Zychowski · 2023 to 2026
$2.1M
Neurovascular Consequences of Inhaled Uranium Mine-Site Dust ExposureR00ES029104 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ZYCHOWSKI, KATHERINE · 2020 to 2022
$743k
Particulate Matter-Induced Pulmonary Exosomes and the Lung-Brain AxisR21ES032432 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ZYCHOWSKI, KATHERINE · 2021 to 2022
$417k
Neurovascular Consequences of Inhaled Uranium Mine-Site Dust ExposureK99ES029104 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ZYCHOWSKI, KATHERINE · 2018 to 2019
$172k
NCATS NIH HHS UL1 TR001449NIEHS NIH HHS K99 ES029104NIEHS NIH HHS P30 ES032755NIEHS NIH HHS P42 ES025589NIEHS NIH HHS R00 ES029104NIEHS NIH HHS R01 ES033981NIEHS NIH HHS R21 ES032432NIGMS NIH HHS P20 GM121176
6 · The paper itself

Abstract

Introduction: The Southwestern United States (SWUS) has an extensive history of coal and metal mining, including uranium (U) mining. Lung diseases, including but not limited to, lung cancer and pulmonary fibrosis, have been studied extensively in miners due to occupational, dust-related exposures. However, high-throughput autoimmune biomarkers are largely understudied in miners, despite the fact that ore miners, such as U-miners, are at an increased risk for the development of autoimmune diseases such as systemic sclerosis and systemic lupus erythematosus (SLE). Additionally, there are current gaps in knowledge regarding which signaling pathways may play a role in occupational exposure-associated autoimmunity. Methods: Most current and former miners in the SWUS live close to their previous workplaces, in remote areas, with limited access to healthcare. In this pilot study, by leveraging a mobile clinical platform for patient care and clinical outreach, we recruited 44 miners who self-identified as either U (n = 10) or non-U miners (n = 34) and received health screenings. Serum IgG and IgM autoantibodies against 128 antigens were assessed using a high-throughput molecular technique, as a preliminary health screening opportunity. Results: Even when adjusting for age as a covariate, there was a significant (p < 0.05) association between self-reported U-mining exposure and biomarkers including IgM alpha-actinin, histones H2B, and H4, myeloperoxidase (MPO) and myelin basic protein. However, adjusting for age did not result in significant associations for IgG autoantibody production in U-miners. Bioinformatic pathway analysis revealed several altered signaling pathways between IgM and IgG autoantibodies among both U and non-U miners. Conclusions: Further research is warranted regarding the mechanistic connection between U-exposure and autoantibody development, especially regarding histone-related alterations and IgM autoantibody production.

Indexed as

AutoantibodyAutoimmunityMinersUranium

Identifiers

PMID36942097
PMCPMC10023988
OpenAlexW4323657883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.